Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-07

Clinical Trial Update: Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

View source ↗

Summary

This clinical trial update describes efforts to identify patients with previously unrecognized, treatable diabetic macular edema for potential intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elman Retina Group | Conditions: Diabetic Macular Edema | Status: UNKNOWN